Aquinox Pharmaceuticals Current Ratio 2013-2018 | AQXP

Aquinox Pharmaceuticals current ratio from 2013 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aquinox Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.09B $0.01B 8.12
2018-06-30 $0.10B $0.01B 7.74
2018-03-31 $0.09B $0.01B 10.07
2017-12-31 $0.11B $0.01B 9.93
2017-09-30 $0.12B $0.01B 17.23
2017-06-30 $0.13B $0.01B 16.26
2017-03-31 $0.12B $0.01B 21.02
2016-12-31 $0.10B $0.01B 10.87
2016-09-30 $0.15B $0.01B 17.12
2016-06-30 $0.07B $0.01B 7.96
2016-03-31 $0.07B $0.01B 12.14
2015-12-31 $0.08B $0.01B 15.61
2015-09-30 $0.12B $0.00B 30.56
2015-06-30 $0.03B $0.00B 7.47
2015-03-31 $0.04B $0.01B 7.04
2014-12-31 $0.04B $0.01B 7.55
2014-09-30 $0.04B $0.01B 8.83
2014-06-30 $0.04B $0.00B 12.77
2014-03-31 $0.06B $0.00B 45.45
2013-12-31 $0.02B $0.00B 5.84
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 5.42
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.063B $0.000B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Bausch Health Cos (BHC) Canada $8.901B 6.44
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.817B 3.03
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.017B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00